OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Cardiology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Vascular regenerative cells in cardiometabolic disease	83
Pemafibrate and other triglyceride-lowering therapies to reduce risk of cardiovascular and metabolic disease	34
Assessment and management of neonates with unrepaired congenital heart disease	28
Persistent inflammatory residual risk despite aggressive cholesterol-lowering therapy: what is next?	19
Editorial introductions	18
Editorial: from albuminuria to uric acid – emerging risk factors beyond lipids	17
Advances in device-based therapies for cardiorenal syndrome	16
REVIVED BCIS-2: update and key learnings	15
Genetics of sudden cardiac death	15
Role of medical management of cardiogenic shock in the era of mechanical circulatory support	14
Device therapy for heart failure management	14
Donation after circulatory determination of death in heart transplant: impact on current and future allocation policy	13
Epigenetic remodeling in heart failure with preserved ejection fraction	13
Editorial introductions	13
Clinical considerations and pathophysiological associations among obesity, weight loss, heart failure, and hypertension	12
Cryoballoon atrial fibrillation ablation experience in Japan	12
Editorial introductions	11
Team-based strategies to prevent heart failure	11
Cardiac phenotypes in LMNA mutations	10
Imaging of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy	10
Wellness and burnout in cardiac surgery: not black and white	10
Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care	10
Cardiac selectivity in pulsed field ablation	10
Radiofrequency lesion formation prediction with contact force versus local impedance	10
Editorial introductions	10

Challenges in diagnosis and management of coarctation of the aorta	10
The impact of transcatheter edge-to-edge repair on mitral valve annular geometry	10
Coronary artery bypass grafting in low ejection fraction: state of the art	10
Multimodality cardiovascular imaging in hypertension	10
Recent clinical trials in atrial fibrillation	10
Management of hypertension in heart transplant recipients: an ongoing conundrum	9
Contemporary management of infective native aortic aneurysms	9
Sleep apnea and cardiovascular risk	8
The mitral valve in hypertrophic cardiomyopathy	8
Integration of palliative care across the spectrum of heart failure care and therapies: considerations, contemporary data, and challenges	8
Management of difficult coronary anatomy during transcatheter aortic valve implantation: what are the key issues?	8
Near infrared spectroscopy in the pediatric cardiac intensive care unit: accurately interpreting the data	8
Bicuspid aortic valve associated aortopathy: 2022 guideline update	8
Weight loss and atrial fibrillation: a review	8
Impact of glucagon-like peptide-1 receptor agonists on hypertension management: a narrative review	7
Improving outcomes after low-risk coronary artery bypass grafting: understanding phase of care mortality analysis, failure to rescue and recent perioperative recommendations	7
Update on the molecular landscape of thoracic aortic aneurysmal disease	7
Expanding revascularization trials to women and underserved minorities and shifting to patient-centered outcomes: RECHARGE trials program	7
Factor XI inhibitors: what should clinicians know	7
Albuminuria and cardiorenal risk	7
Is the world ready for the STICH 3.0 trial?	7
Electrographic flow mapping of atrial fibrillation	7
New wrinkles in hypertension management 2022	7
Catheter-based therapies in acute and chronic pulmonary embolism	6
Less invasive multivessel coronary artery bypass grafting: now is the time	6
When should the tricuspid valve be repaired during mitral valve repair?	6
Epidemiology and risk factors for stroke in young individuals: implications for prevention	6
Promoting gender diversity and ergonomic equity in the cardiac surgery operating room	6
Current and future transcatheter aortic valve replacement valves	6
Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?	6
The pleiotropic cardiovascular effects of sodium-glucose cotransporter-2 inhibitors	6
Bad behavior in healthcare: an insidious threat to patients, staff, and organizations	6
Editorial introductions	6
Long noncoding RNAs in cardiovascular disease	5
Disparity issues in coronary artery surgery	5
Improving diversity in cardiac surgery clinical trials with ROMA:Women as an exemplar	5
Electronic health strategies to improve medication adherence in patients with cardiometabolic disease: current status and future directions	5
Artificial sweeteners and cardiovascular risk	5
Clinical trials of cell therapy for heart failure: recent results warrant continued research	5
Editorial introductions	5
Peripheral arterial disease and hypertension	5
How to deal with nonsevere stenoses in coronary artery bypass grafting – a critical perspective on competitive flow and surgical precision	5
Left main revascularization guidelines: navigating the data	5
Coronary plaque features on CTA can identify patients at increased risk of cardiovascular events	5
A tale of two balloons: technical and procedural difference between cryoballoon systems	5
Robotic mitral valve surgery: evolving history, techniques, and training paths	5
Destination LVAD therapy in the current era of the heart transplant allocation system	5
Coronary artery calcium and sudden cardiac death: current evidence and future directions	4
Editorial introductions	4
Statin-Associated muscle symptoms and vitamin D supplementation	4

The management of new-onset atrial fibrillation in critical illness: an update on current therapeutic options	4
Building resilient heart center teams	4
Optimal medical therapy after coronary artery bypass grafting: a primer for surgeons	4
Management of pregnancy in left ventricular assist device and heart transplant recipients: a concise review	4
Clinical impact of genetic testing for lipid disorders	4
Mitral valve surgery after failed transcatheter edge-to-edge repair: a review and word of caution	4
Arrhythmogenic right ventricular cardiomyopathy in the pediatric population	4
Ischemic mitral regurgitation: when should one intervene?	4
Editorial: the year in lipids and emerging risk factors	4
Influenza vaccination in mitigating vascular events and risk	4
Editorial: Current opinion on controversial issues in coronary artery bypass surgery	4
Chronic thromboembolic pulmonary hypertension anno 2021	4
Editorial introductions	4
Double outlet right ventricle – the 50% rule has always been about the conus	4
Brugada syndrome – minimizing overdiagnosis and over treatment in children	4
Pharmacogenetics of cardiovascular drugs	4
High lipoprotein(a) is a risk factor for peripheral artery disease, abdominal aortic aneurysms, and major adverse limb events	4